An exploration into the lives of Teenagers and Young adults with autism spectrum disorder – An Operational Research Study
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2021 - 2027
Project Lead
Dr. Suhas Chandran
Authors
Vanitha s Rao, Nisba Tasmin, Malavika vinayan, Job G Samuel
Project Status
ongoing
Project Type
PI